Dextrose Monohydrate 50% Injection Shortage

Last Updated: September 16, 2025
Status: Current

Unavailable, Current:

• Dextrose Monohydrate 50%, Injection, 25 g/50 mL (Hospira, Inc., a Pfizer Company)

Available, Current:

• Dextrose Monohydrate 50%, Injection, 25 g/50 mL (Amphastar Pharmaceuticals, Inc.)
• Dextrose Monohydrate 50%, Injection, 25 g/50 mL (Hospira, Inc., a Pfizer Company)

Dextrose Monohydrate 50%, Injection, 25 g/50 mL (Hospira, Inc., a Pfizer Company)

NDC Code: 0409-4902-34
Availability: Unavailable
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Shortage per Manufacturer: Manufacturing Delay
Therapeutic category: Endocrinology/Metabolism; Gastroenterology; Pediatric
Initial posting date: January 13, 2022
Contact info: 844-646-4398

Dextrose Monohydrate 50%, Injection, 25 g/50 mL (Amphastar Pharmaceuticals, Inc.)

NDC Code: 76329-3302-1
Availability: Available
Status: Current
Date of update: September 16, 2025
Update type: Reverified
Therapeutic category: Endocrinology/Metabolism; Gastroenterology; Pediatric
Initial posting date: January 13, 2022
Contact info: 800-423-4136

Dextrose Monohydrate 50%, Injection, 25 g/50 mL (Hospira, Inc., a Pfizer Company)

NDC Code: 0409-7517-16
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Revised
Therapeutic category: Endocrinology/Metabolism; Gastroenterology; Pediatric
Initial posting date: January 13, 2022
Contact info: 844-646-4398

Dextrose Monohydrate 50%, Injection, 25 g/50 mL (Hospira, Inc., a Pfizer Company)

NDC Code: 0409-6648-02
Availability: Available
Status: Current
Date of update: August 15, 2025
Update type: Reverified
Therapeutic category: Endocrinology/Metabolism; Gastroenterology; Pediatric
Initial posting date: January 13, 2022
Contact info: 844-646-4398

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer